Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.8 USD | -0.18% | -11.40% | +29.25% |
05:15pm | Immunome Completes Purchase of Antibodies From Atreca | MT |
May. 17 | Immunome Appoints Max Rosett as CFO | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.25% | 829M | |
+9.70% | 115B | |
+11.73% | 106B | |
-2.59% | 21.96B | |
-13.33% | 21.87B | |
-5.29% | 19.21B | |
-4.37% | 18.08B | |
-38.57% | 17.71B | |
+6.55% | 14.32B | |
+34.03% | 12.42B |
- Stock Market
- Equities
- IMNM Stock
- News Immunome, Inc.
- Wedbush Raises Immunome's PT to $27 From $19 on Heels of Announced Plans to Acquire AL101, AL102 From Ayala Pharmaceuticals; Keeps Outperform Rating